Skip to main content
Veterinary Medicines

Zoosaloral R

Not authorised
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, histidine-adenine auxotrophic, Live

Product identification

Medicine name:
Zoosaloral R
Active substance:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, histidine-adenine auxotrophic, Live
Target species:
  • Cattle (suckling calf)
  • Cattle
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, histidine-adenine auxotrophic, Live
    1000000.00
    million colony forming units
    /
    1.00
    Dose
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Cattle (suckling calf)
      • Meat and offal
        3
        week
    • Cattle
      • Milk
        3
        week
      • Meat and offal
        3
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AE02
Authorisation status:
  • Surrendered
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Tiergesundheit GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • IDT Biologika GmbH
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 214a/92
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 27/02/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 27/02/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."